Hybrid Treatment: Expanding the Armamentarium for Infected Infrarenal Abdominal Aortic and Iliac Aneurysms

Kichang Han, Do Yun Lee, ManDeuk Kim, Sak Lee, Jong Yun Won, Joon Ho Kwon, Donghoon Choi, Young Guk Ko

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose To investigate safety and efficacy of hybrid treatment for infected aortic and iliac aneurysms. Materials and Methods Between July 2007 and May 2011, hybrid treatment was performed in 6 male patients (mean age, 67.7 y; range, 57–76 y). Hybrid treatment consisted of extraanatomic bypass (EAB) and isolation of infected aneurysm with vascular plugs. Aneurysms were divided into primary and secondary infected aneurysms. Primary infected aneurysm refers to an aneurysm arising from bacterial infection of the native arterial wall; secondary infected aneurysm refers to infection involving an aneurysm that was previously treated with graft placement. Results The infected aneurysm involved the infrarenal abdominal aorta in 4 patients and common iliac artery in 2 patients. Hybrid treatment was successful in all 6 patients. The 3 patients with primary infected aneurysms required only hybrid treatment, whereas infected graft excision and new graft interposition was performed in 2 of the 3 patients with secondary infected aneurysms. No 30-day mortality or complications were reported. During mean follow-up of 58.6 months (range, 32.6–75.8 months), 1 patient (17%) with a secondary infected aneurysm who did not undergo additional surgery died 32.6 months after hybrid treatment from hypovolemic shock secondary to recurrent aortoenteric fistula. Cumulative survival was 100%, 100%, 83%, and 83% at 3 months, 1 year, 3 years, and 5 years. Conclusions Hybrid treatment appears to be a stand-alone, curative treatment for primary infected aneurysms and serves as bridge therapy to subsequent surgery for secondary infected aneurysms.

Original languageEnglish
Pages (from-to)564-569
Number of pages6
JournalJournal of Vascular and Interventional Radiology
Volume28
Issue number4
DOIs
Publication statusPublished - 2017 Apr 1

Fingerprint

Iliac Aneurysm
Infected Aneurysm
Abdominal Aortic Aneurysm
Therapeutics
Aneurysm
Transplants
Aortic Aneurysm
Iliac Artery
Abdominal Aorta
Bacterial Infections
Fistula
Blood Vessels
Shock

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Han, Kichang ; Lee, Do Yun ; Kim, ManDeuk ; Lee, Sak ; Won, Jong Yun ; Kwon, Joon Ho ; Choi, Donghoon ; Ko, Young Guk. / Hybrid Treatment : Expanding the Armamentarium for Infected Infrarenal Abdominal Aortic and Iliac Aneurysms. In: Journal of Vascular and Interventional Radiology. 2017 ; Vol. 28, No. 4. pp. 564-569.
@article{24937cc78811462f8e4a0d05b26251ac,
title = "Hybrid Treatment: Expanding the Armamentarium for Infected Infrarenal Abdominal Aortic and Iliac Aneurysms",
abstract = "Purpose To investigate safety and efficacy of hybrid treatment for infected aortic and iliac aneurysms. Materials and Methods Between July 2007 and May 2011, hybrid treatment was performed in 6 male patients (mean age, 67.7 y; range, 57–76 y). Hybrid treatment consisted of extraanatomic bypass (EAB) and isolation of infected aneurysm with vascular plugs. Aneurysms were divided into primary and secondary infected aneurysms. Primary infected aneurysm refers to an aneurysm arising from bacterial infection of the native arterial wall; secondary infected aneurysm refers to infection involving an aneurysm that was previously treated with graft placement. Results The infected aneurysm involved the infrarenal abdominal aorta in 4 patients and common iliac artery in 2 patients. Hybrid treatment was successful in all 6 patients. The 3 patients with primary infected aneurysms required only hybrid treatment, whereas infected graft excision and new graft interposition was performed in 2 of the 3 patients with secondary infected aneurysms. No 30-day mortality or complications were reported. During mean follow-up of 58.6 months (range, 32.6–75.8 months), 1 patient (17{\%}) with a secondary infected aneurysm who did not undergo additional surgery died 32.6 months after hybrid treatment from hypovolemic shock secondary to recurrent aortoenteric fistula. Cumulative survival was 100{\%}, 100{\%}, 83{\%}, and 83{\%} at 3 months, 1 year, 3 years, and 5 years. Conclusions Hybrid treatment appears to be a stand-alone, curative treatment for primary infected aneurysms and serves as bridge therapy to subsequent surgery for secondary infected aneurysms.",
author = "Kichang Han and Lee, {Do Yun} and ManDeuk Kim and Sak Lee and Won, {Jong Yun} and Kwon, {Joon Ho} and Donghoon Choi and Ko, {Young Guk}",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.jvir.2016.10.028",
language = "English",
volume = "28",
pages = "564--569",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "4",

}

Hybrid Treatment : Expanding the Armamentarium for Infected Infrarenal Abdominal Aortic and Iliac Aneurysms. / Han, Kichang; Lee, Do Yun; Kim, ManDeuk; Lee, Sak; Won, Jong Yun; Kwon, Joon Ho; Choi, Donghoon; Ko, Young Guk.

In: Journal of Vascular and Interventional Radiology, Vol. 28, No. 4, 01.04.2017, p. 564-569.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hybrid Treatment

T2 - Expanding the Armamentarium for Infected Infrarenal Abdominal Aortic and Iliac Aneurysms

AU - Han, Kichang

AU - Lee, Do Yun

AU - Kim, ManDeuk

AU - Lee, Sak

AU - Won, Jong Yun

AU - Kwon, Joon Ho

AU - Choi, Donghoon

AU - Ko, Young Guk

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Purpose To investigate safety and efficacy of hybrid treatment for infected aortic and iliac aneurysms. Materials and Methods Between July 2007 and May 2011, hybrid treatment was performed in 6 male patients (mean age, 67.7 y; range, 57–76 y). Hybrid treatment consisted of extraanatomic bypass (EAB) and isolation of infected aneurysm with vascular plugs. Aneurysms were divided into primary and secondary infected aneurysms. Primary infected aneurysm refers to an aneurysm arising from bacterial infection of the native arterial wall; secondary infected aneurysm refers to infection involving an aneurysm that was previously treated with graft placement. Results The infected aneurysm involved the infrarenal abdominal aorta in 4 patients and common iliac artery in 2 patients. Hybrid treatment was successful in all 6 patients. The 3 patients with primary infected aneurysms required only hybrid treatment, whereas infected graft excision and new graft interposition was performed in 2 of the 3 patients with secondary infected aneurysms. No 30-day mortality or complications were reported. During mean follow-up of 58.6 months (range, 32.6–75.8 months), 1 patient (17%) with a secondary infected aneurysm who did not undergo additional surgery died 32.6 months after hybrid treatment from hypovolemic shock secondary to recurrent aortoenteric fistula. Cumulative survival was 100%, 100%, 83%, and 83% at 3 months, 1 year, 3 years, and 5 years. Conclusions Hybrid treatment appears to be a stand-alone, curative treatment for primary infected aneurysms and serves as bridge therapy to subsequent surgery for secondary infected aneurysms.

AB - Purpose To investigate safety and efficacy of hybrid treatment for infected aortic and iliac aneurysms. Materials and Methods Between July 2007 and May 2011, hybrid treatment was performed in 6 male patients (mean age, 67.7 y; range, 57–76 y). Hybrid treatment consisted of extraanatomic bypass (EAB) and isolation of infected aneurysm with vascular plugs. Aneurysms were divided into primary and secondary infected aneurysms. Primary infected aneurysm refers to an aneurysm arising from bacterial infection of the native arterial wall; secondary infected aneurysm refers to infection involving an aneurysm that was previously treated with graft placement. Results The infected aneurysm involved the infrarenal abdominal aorta in 4 patients and common iliac artery in 2 patients. Hybrid treatment was successful in all 6 patients. The 3 patients with primary infected aneurysms required only hybrid treatment, whereas infected graft excision and new graft interposition was performed in 2 of the 3 patients with secondary infected aneurysms. No 30-day mortality or complications were reported. During mean follow-up of 58.6 months (range, 32.6–75.8 months), 1 patient (17%) with a secondary infected aneurysm who did not undergo additional surgery died 32.6 months after hybrid treatment from hypovolemic shock secondary to recurrent aortoenteric fistula. Cumulative survival was 100%, 100%, 83%, and 83% at 3 months, 1 year, 3 years, and 5 years. Conclusions Hybrid treatment appears to be a stand-alone, curative treatment for primary infected aneurysms and serves as bridge therapy to subsequent surgery for secondary infected aneurysms.

UR - http://www.scopus.com/inward/record.url?scp=85009223531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009223531&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2016.10.028

DO - 10.1016/j.jvir.2016.10.028

M3 - Article

C2 - 28034703

AN - SCOPUS:85009223531

VL - 28

SP - 564

EP - 569

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 4

ER -